Brazzell Romulus K
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Brazzell Romulus K. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| KALA | SEE REMARKS | Sale | 46,748 | $0.83 | $38,801 | Oct 22, 2025 |
| KALA | SEE REMARKS | Sale | 5,251 | $4.01 | $21,057 | Jun 24, 2025 |
| KALA | SEE REMARKS | Sale | 3,687 | $3.74 | $13,789 | Jun 3, 2025 |
| KALA | SEE REMARKS | Sale | 2,446 | $7.63 | $18,663 | Jan 6, 2025 |
| KALA | SEE REMARKS | Sale | 5,489 | $4.75 | $26,073 | Jun 26, 2024 |
| KALA | SEE REMARKS | Sale | 2,002 | $6.09 | $12,192 | May 31, 2024 |
| KALA | SEE REMARKS | Sale | 1,617 | $6.74 | $10,899 | Jan 4, 2024 |
| KALA | SEE REMARKS | Award / Grant | 49,356 | — | — | Jun 22, 2023 |
| KALA | SEE REMARKS | Award / Grant | 17,916 | — | — | May 31, 2023 |
| KALA | SEE REMARKS | Award / Grant | 12,800 | — | — | Jan 4, 2023 |
| KALA | SEE REMARKS | Sale | 261 | $6.51 | $1,699 | Oct 26, 2022 |
| KALA | SEE REMARKS | Sale | 3,144 | $0.37 | $1,163 | Jun 27, 2022 |
| KALA | SEE REMARKS | Sale | 3,504 | $1.30 | $4,555 | Jan 4, 2022 |
| KALA | CHIEF MEDICAL OFFICER | Sale | 12,757 | $1.80 | $22,963 | Oct 26, 2021 |
| KALA | CHIEF MEDICAL OFFICER | Sale | 3,034 | $5.77 | $17,506 | Jun 28, 2021 |
| KALA | Chief Medical Officer | Award / Grant | 27,500 | — | — | Jan 4, 2021 |
| KALA | Chief Medical Officer | Award / Grant | 81,000 | — | — | Oct 26, 2020 |
| KALA | Chief Medical Officer | Award / Grant | 19,000 | — | — | Jun 25, 2020 |
| KALA | Chief Medical Officer | Option Exercise | 47,644 | $3.34 | $159,131 | Apr 9, 2020 |
| KALA | Chief Medical Officer | Option Exercise | 44,313 | $2.30 | $101,920 | Aug 11, 2017 |
| 0001040416 | EVP, Medical & Scientific | Disposition | 20,000 | $5.00 | $100,000 | May 13, 2011 |
| 0001040416 | Sr. VP, Ophthalmic R & D | Award / Grant | 20,000 | — | — | Jul 21, 2006 |